# MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ma12-08-chemotherapy-plus-egfr-tkis-or-bevacizumab-versus-chemotherapy-alone-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C. Zhang,S Zhang,Yingshui Yao,Yanan Gao,Jihong Huang,Kai‐Cheng Peng,Qiang Gao,Hu Chen,Chong‐Rui Xu,Xinyuan Zhang,Ying Wu,Jianjun Yang |
| Citations | 7 |
| DOI | 10.1016/j.jtho.2021.01.259 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3138071985 |
| Type | conference-abstract |
| Year | 2021 |

## Paper authors

- [Yingshui Yao](https://scholariq.org/researchers/yingshui-yao/)
- [Chong‐Rui Xu](https://scholariq.org/researchers/chong-rui-xu/)
- [Qiang Gao](https://scholariq.org/researchers/qiang-gao/)
- [Ying Wu](https://scholariq.org/researchers/ying-wu-2/)
- [Xinyuan Zhang](https://scholariq.org/researchers/xinyuan-zhang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.